Natalie McClure, SVP, Product Development at Adamas Pharmaceuticals Inc (ADMS), sold 36,000 shares at $18.50 ($666K) on 2016-04-18, disclosed to the SEC on 2016-04-20.
Open-market sale of $666k ADMS by SVP, Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.50 | 12,666 | $234K | 35.2% |
| 2 | $18.50 | 23,334 | $432K | 64.8% |
| Total | $18.50 avg | 36,000 | $666K | 100% |
| Filing → |
| ADMS | SELL | 2015-04-07 | $35K | — | Filing → |
| ADMS | SELL | 2015-03-09 | $34K | — | Filing → |
| ADMS | SELL | 2015-02-06 | $34K | — | Filing → |